ACPD treatment had similar effects to oral GlyMCA on the prevention of CGD (Figure 2A,B–D right panels; Figure S8A–D; Tables S1H and S2C, Supporting Information) and on the inhibition of gallbladder MUC1 expression (Figure 3C,D) in WD‐fed miceC70‐KO. This evidence concerns the gene MUC1 and chronic granulomatous disease.